Efficacy and safety of different interventions in castration resistant prostate cancer progressing after docetaxel-based chemotherapy: Bayesian network analysis of randomized controlled trials

Background: Most patients receiving docetaxel-based chemotherapy for castration resistant prostate cancer (CRPC) will eventually progress, and the optimal interventions for these patients are controversial. The objective of our study is to evaluate the clinical efficacy and safety of pharmacological...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yue, Huang, Hao, Chen, Changhao, Liu, Hao, Liu, Hongwei, Su, Feng, Bi, Junming, Lam, Thomas B., Li, Jiaping, Lin, Tianxin, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858491/
https://www.ncbi.nlm.nih.gov/pubmed/29556327
http://dx.doi.org/10.7150/jca.22365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858491/
https://www.ncbi.nlm.nih.gov/pubmed/29556327
http://dx.doi.org/10.7150/jca.22365

Ejemplares similares